Ozempic, the brand name for semaglutide, has become a hot topic in recent months. Originally FDA-approved for managing insulin levels in type 2 diabetes patients, its off-label use for weight management has sparked significant interest, particularly among celebrities. This surge in popularity has led to an ongoing shortage of the drug, raising questions about its widespread use and potential side effects.